Ahmed Al Hasan

Ahmed Al Hasan

Auto-generated profile, based on publicly available information

Ahmed Al Hasan

Department of Rheumatology, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333ZA, The Netherlands, 31 0715269111

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2022 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
AHAhmed Al Hasan
Ahmed Al Hasan
FRFloor Reimann
Floor Reimann
NVNic Veeger
Nic Veeger
SBSytske Anne Bergstra
Sytske Anne Bergstra
DZDan Zhang
Dan Zhang
RBReinhard Bos
Reinhard Bos

15 March 2019 in European Urology Supplements
Verified
Journal Article
Closed access
NIN. Iqbal
N. Iqbal
AHA. Hasan
A. Hasan
AIA. Iqbal
A. Iqbal
AZA. Zia
A. Zia
UAU. Alam
U. Alam
SAS. Akhter
S. Akhter

17 November 2025 in JMIR Medical Informatics
Verified
Journal Article
Open access
TMTjardo Daniël Maarseveen
Tjardo Daniël Maarseveen
FRFloor Reimann
Floor Reimann
AHAhmed al Hasan
Ahmed al Hasan
ASAnnemarie Schilder
Annemarie Schilder
DZDan Zhang
Dan Zhang
RBReinhard Bos
Reinhard Bos
Background: Inflammatory rheumatic diseases (IRDs) affect 5% of the general population, whereas 35% of the population experiences musculoskeletal concerns. IRDs cause early disability, reduced life expectancy, and considerable health care costs. Early diagnosis is essential to prevent long-term damage. Similarly important is the early identification of patients with musculoskeletal concerns without IRDs to prevent unnecessary health care expenses. Of the population referred to the rheumatologist, 60% have noninflammatory musculoskeletal concerns, whereas only 20% of patients with an IRD see a rheumatologist within 3 months of symptom onset. The need for digital predictive (triage) tools for rheumatic and musculoskeletal diseases led to the development of the Frysian Questionnaire for Differentiation of Musculoskeletal Complaints (FRYQ). Objective: This study aimed to assess whether the FRYQ can distinguish IRD from noninflammatory musculoskeletal concerns in general, and rheumatoid arthritis and fibromyalgia specifically, in newly referred patients. Methods: The FRYQ is an 87-item tool (20 open-ended and 67 closed-ended questions) used to triage new rheumatology patients at Frisius Medical Center in the Netherlands. We analyzed data from 2 sources: dataset A with 728 outpatient clinic patients and dataset B with 373 patients from the Joint Pain Assessment Scoring Tool study. We built a classifier using Extreme Gradient Boosting to distinguish inflammatory from noninflammatory conditions based on closed-ended questions. Using elastic net regularization, we identified the most informative questions. We evaluated classification using receiver operating characteristic curve analysis and assessed feature importance through Shapley Additive Explanation analysis. To test generalizability, we replicated our analysis on dataset B. Finally, we examined whether the questions of the FRYQ could be used to identify specific conditions beyond the general categories of IRD and non-IRD, specifically for detecting fibromyalgia and rheumatoid arthritis. Results: Feature selection reduced the questionnaire from 67 to 28 items while maintaining discriminative power. After initial development, the model achieved an area under the receiver operating characteristic curve (AUC-ROC) of 0.72 (95% CI 0.67-0.78) for distinguishing inflammatory from noninflammatory conditions in an external validation set. Using a probability threshold of 0.30, the model achieved 71% sensitivity and 56% specificity on external validation. The FRYQ demonstrated stronger performance in identifying specific diagnoses such as fibromyalgia (AUC-ROC=0.81) and rheumatoid arthritis (AUC-ROC=0.77). Key discriminating features included symptom duration, pain response to movement, and anti-inflammatory medication effectiveness. Conclusions: The FRYQ effectively distinguishes inflammatory from noninflammatory rheumatic conditions before specialist consultation and shows particular strength in identifying fibromyalgia and rheumatoid arthritis. This tool could improve rheumatology triage by prioritizing referrals with high likelihood of IRD for early rheumatologist evaluation while directing other patients to appropriate alternative resources. Prospective studies are needed to determine the FRYQ’s impact on clinical outcomes and health care efficiency.